Integrins-a Relevant Target in Glioblastoma.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
Works matching IS 17598958 AND DT 2010 AND VI 2 AND IP 1
Results: 26
1
2
Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
3
Central Nervous System Involvement in Mantle Cell Lymphoma.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
4
Vitamin D Deficiency in Multiple Myeloma.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
5
Unmet Medical Needs in Glioblastoma Management and Optimal Sequencing of the Emerging Treatment Options.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 41
- By:
- Publication type:
- Article
6
Treatment Strategies for Relapsed or Refractory Peripheral T-cell Lymphomas.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 139
- By:
- Publication type:
- Article
7
Trabectedin: An Emerging Therapeutic Option in Soft Tissue Sarcoma.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
8
Triapine in Clinical Practice.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
9
Treating the Anemic Oncology Patient with Intravenous Iron: Why, When, and How?
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 111
- By:
- Publication type:
- Article
10
The Role of Portal Vein Embolization Prior to Hepatic Resection for Primary and Secondary Hepatic Malignancies.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
11
The Evolving Role of <sup>18</sup>F-FDG PET Scans in Patients with Aggressive non-Hodgkin's Lymphoma.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
12
Targeting Angiogenesis in Non-Small Cell Lung Cancer: Agents in Practice and Clinical Development.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 31
- By:
- Publication type:
- Article
13
Severe Skin Lesions in Patients with Glioblastoma Multiforme Treated with a Combination of Cetuximab, Bevacizumab, and Irinotecan.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
14
Role and Prognostic Significance of the Ki-67 Index in Non-Hodgkin's Lymphoma.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
15
ProGRP: A New Biomarker for Small Cell Lung Cancer.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 25
- By:
- Publication type:
- Article
16
Predictive Markers for Chemotherapy Toxicity: an Important Factor in Personalized Therapy.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
17
Management of Infectious Complications in Chronic Lymphocytic Leukemia.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
18
Intravenous Bisphosphonates for Preventing Bone Loss in Allogeneic Stem Cell Recipients.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
19
Docetaxel and Irinotecan Combination Chemotherapy in Advanced Esophageal Cancer.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
20
Comprehensive Meta-Analysis of Survival Outcomes from Two Randomized Multicenter Trials in First-Line Advanced Non-Small Cell Lung Cancer in Patients Treated with the Novel Investigational Antitumor-enhancing and Chemoprotective Agent Tavocept.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 7
- By:
- Publication type:
- Article
21
Circulating Tumor Cells: A Potential Bladder Cancer Biomarker?
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 105
- By:
- Publication type:
- Article
22
ALK-Positive Diffuse Large B-cell Lymphoma: An Aggressive Clinicopathological Entity.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
23
Acute myeloid leukemia after breast cancer: therapy related or host associated?
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
24
Anti-Angiogenesis Therapy in the Treatment of Non-Small Cell Lung Cancer: The Role of Monoclonal Antibodies and Multitargeted Tyrosine Kinase Inhibitors.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 23
- By:
- Publication type:
- Article
25
Chemotherapy in Head and Neck Cancers: Summary of Recommendations and a Critical Review of Clinical Practice Guidelines.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
26
Adjuvant Radiotherapy and Chemotherapy for Resected Pancreatic Adenocarcinoma: Review of Current Evidence.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article